From the AMR Consensus Conference in Heart Transplantation, the presence of donor-specific antibodies (DSA) was not mandated as a definition for AMR. Yet, DSA has been correlated to subsequent poor outcome. This talk will delve into the importance of DSA with respect to AMR in heart transplantation. In addition, the application and significance of the new C1q assay for complement fixation by DSA will be discussed.

What You'll Take Away from His Talk:

Understand the importance of developing DSA after heart transplantation.
Be informed on the practical use of the new C1q assay.
Determine the clinical relevance of DSA.

Dr. Jon Kobashigawa MD

Appearances